Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut.

Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ.

BMJ. 2002 Oct 5;325(7367):740.

PMID:
12364300
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up.

Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery E, Barry MJ.

J Gen Intern Med. 2008 Nov;23(11):1809-14. doi: 10.1007/s11606-008-0785-8. Epub 2008 Sep 16.

PMID:
18795372
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Changes in prostate cancer incidence and treatment in USA.

Lu-Yao GL, Greenberg ER.

Lancet. 1994 Jan 29;343(8892):251-4.

PMID:
7905093
[PubMed - indexed for MEDLINE]
4.

Urban-rural differences in prostate cancer mortality, radical prostatectomy and prostate-specific antigen testing in Australia.

Coory MD, Baade PD.

Med J Aust. 2005 Feb 7;182(3):112-5.

PMID:
15698354
[PubMed - indexed for MEDLINE]
5.

Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients.

Potosky AL, Merrill RM, Riley GF, Taplin SH, Barlow W, Fireman BH, Lubitz JD.

Health Serv Res. 1999 Jun;34(2):525-46.

PMID:
10357289
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Follow-up prostate cancer treatments after radical prostatectomy: a population-based study.

Lu-Yao GL, Potosky AL, Albertsen PC, Wasson JH, Barry MJ, Wennberg JE.

J Natl Cancer Inst. 1996 Feb 21;88(3-4):166-73.

PMID:
8632490
[PubMed - indexed for MEDLINE]
Free Article
7.

Screening for prostate cancer: updated experience from the Tyrol study.

Horninger W, Berger A, Pelzer A, Klocker H, Oberaigner W, Schönitzer D, Severi G, Robertson C, Boyle P, Bartsch G.

Can J Urol. 2005 Feb;12 Suppl 1:7-13; discussion 92-3.

PMID:
15780158
[PubMed - indexed for MEDLINE]
8.

Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.

Nieder AM, Porter MP, Soloway MS.

J Urol. 2008 Nov;180(5):2005-9; discussion 2009-10. doi: 10.1016/j.juro.2008.07.038. Epub 2008 Sep 17.

PMID:
18801517
[PubMed - indexed for MEDLINE]
9.

Rise and fall of radical prostatectomy rates from 1989 to 1996.

Sheikh K, Bullock C.

Urology. 2002 Mar;59(3):378-82.

PMID:
11880074
[PubMed - indexed for MEDLINE]
10.

Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994.

Newcomer LM, Stanford JL, Blumenstein BA, Brawer MK.

J Urol. 1997 Oct;158(4):1427-30.

PMID:
9302136
[PubMed - indexed for MEDLINE]
11.

Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.

D'Amico AV, Hui-Chen M, Renshaw AA, Sussman B, Roehl KA, Catalona WJ.

J Urol. 2006 Dec;176(6 Pt 2):S11-5.

PMID:
17084157
[PubMed - indexed for MEDLINE]
12.

The role of increasing detection in the rising incidence of prostate cancer.

Potosky AL, Miller BA, Albertsen PC, Kramer BS.

JAMA. 1995 Feb 15;273(7):548-52.

PMID:
7530782
[PubMed - indexed for MEDLINE]
13.

Prostate cancer mortality in Connecticut, Iowa and New Mexico African American men.

Escobedo LG, Rivas SD, Holmes MD.

Cancer Detect Prev. 2004;28(5):375-80.

PMID:
15542264
[PubMed - indexed for MEDLINE]
14.

Prostate cancer and the Will Rogers phenomenon.

Albertsen PC, Hanley JA, Barrows GH, Penson DF, Kowalczyk PD, Sanders MM, Fine J.

J Natl Cancer Inst. 2005 Sep 7;97(17):1248-53.

PMID:
16145045
[PubMed - indexed for MEDLINE]
Free Article
15.

Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.

Agalliu I, Weiss NS, Lin DW, Stanford JL.

Cancer Causes Control. 2007 Nov;18(9):931-7. Epub 2007 Jul 20.

PMID:
17641982
[PubMed - indexed for MEDLINE]
16.

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC.

J Natl Cancer Inst. 2004 Sep 15;96(18):1358-67.

PMID:
15367568
[PubMed - indexed for MEDLINE]
Free Article
17.

Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.

Zhu X, van Leeuwen PJ, Bul M, Otto SJ, de Koning HJ, Bangma CH, Schröder FH, Roobol MJ.

Eur Urol. 2011 Aug;60(2):330-6. doi: 10.1016/j.eururo.2011.05.013. Epub 2011 May 17.

PMID:
21601352
[PubMed - indexed for MEDLINE]
18.

Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study.

Stattin P, Holmberg E, Johansson JE, Holmberg L, Adolfsson J, Hugosson J; National Prostate Cancer Register (NPCR) of Sweden.

J Natl Cancer Inst. 2010 Jul 7;102(13):950-8. doi: 10.1093/jnci/djq154. Epub 2010 Jun 18.

PMID:
20562373
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Mammography use, breast cancer stage at diagnosis, and survival among older women.

McCarthy EP, Burns RB, Freund KM, Ash AS, Shwartz M, Marwill SL, Moskowitz MA.

J Am Geriatr Soc. 2000 Oct;48(10):1226-33.

PMID:
11037009
[PubMed - indexed for MEDLINE]
20.

Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.

Roobol MJ, Grenabo A, Schröder FH, Hugosson J.

J Natl Cancer Inst. 2007 Sep 5;99(17):1296-303. Epub 2007 Aug 28.

PMID:
17728218
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk